XIPERE Trademark

Trademark Overview

On Friday, April 27, 2018, a trademark application was filed for XIPERE with the United States Patent and Trademark Office. The USPTO has given the XIPERE trademark a serial number of 87896124. The federal status of this trademark filing is REGISTERED as of Tuesday, March 15, 2022. This trademark is owned by Clearside Biomedical, Inc.. The XIPERE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Ocular pharmaceuticals; ophthalmic preparations

Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems
xipere

General Information

Serial Number87896124
Word MarkXIPERE
Filing DateFriday, April 27, 2018
Status700 - REGISTERED
Status DateTuesday, March 15, 2022
Registration Number6672372
Registration DateTuesday, March 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2018

Trademark Statements

Certificate of Correction for RegistrationIn the Statement, line 2, should be deleted, and, "Suite 200, 900 North Point Parkway" should be inserted.
Goods and ServicesOcular pharmaceuticals; ophthalmic preparations
Goods and ServicesMedical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 5, 2018
Primary Code005
First Use Anywhere DateMonday, December 13, 2021
First Use In Commerce DateMonday, December 13, 2021
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, May 5, 2018
Primary Code010
First Use Anywhere DateMonday, December 13, 2021
First Use In Commerce DateMonday, December 13, 2021

Trademark Owner History

Party NameClearside Biomedical, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30005
Party NameClearside Biomedical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30005
Party NameClearside Biomedical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30005

Trademark Events

Event DateEvent Description
Saturday, September 3, 2022REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Saturday, September 3, 2022CORRECTION UNDER SECTION 7 ¿ PROCESSED
Wednesday, August 31, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 1, 2022TEAS SECTION 7 REQUEST RECEIVED
Tuesday, March 15, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, February 9, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 8, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, January 8, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 6, 2022USE AMENDMENT FILED
Thursday, January 6, 2022TEAS STATEMENT OF USE RECEIVED
Friday, September 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 16, 2021SOU EXTENSION 5 GRANTED
Tuesday, September 7, 2021SOU EXTENSION 5 FILED
Tuesday, September 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 7, 2021TEAS EXTENSION RECEIVED
Wednesday, January 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 25, 2021SOU EXTENSION 4 GRANTED
Monday, January 25, 2021SOU EXTENSION 4 FILED
Monday, January 25, 2021TEAS EXTENSION RECEIVED
Friday, September 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 16, 2020SOU EXTENSION 3 GRANTED
Wednesday, September 16, 2020SOU EXTENSION 3 FILED
Wednesday, September 16, 2020TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, August 12, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, March 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 3, 2020SOU EXTENSION 2 GRANTED
Tuesday, March 3, 2020SOU EXTENSION 2 FILED
Tuesday, March 3, 2020TEAS EXTENSION RECEIVED
Tuesday, August 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 16, 2019SOU EXTENSION 1 GRANTED
Friday, August 16, 2019SOU EXTENSION 1 FILED
Friday, August 16, 2019TEAS EXTENSION RECEIVED
Monday, July 8, 2019ASSIGNED TO EXAMINER
Tuesday, March 19, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, February 3, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, October 25, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 25, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 17, 2018ASSIGNED TO EXAMINER
Wednesday, July 11, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, July 11, 2018ASSIGNED TO LIE
Thursday, June 21, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, May 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, May 2, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 2, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 1, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

xipere injection delivery pharmaceuticals system needles based needle ophthalmic medical devices